Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LENIOLISIB vs LETROZOLE\RIBOCICLIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LENIOLISIB vs LETROZOLE\RIBOCICLIB: Safety Overview

Metric LENIOLISIB LETROZOLE\RIBOCICLIB
Total FAERS Reports 570 621
Deaths Reported 6 78
Death Rate 1.1% 12.6%
Hospitalizations 54 80
Average Patient Age 19.4 yrs 64.2 yrs
% Female Patients 27.3% 98.2%
FDA Approval Date Mar 24, 2023 N/A
Manufacturer Pharming Healthcare Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A